ONCASPAR 750 [iU]/mL
Pegaspargase · INJECTION, SOLUTION · Servier Pharmaceuticals LLC
Oncaspar is a prescription injection used to treat certain types of leukemia and lymphoma as part of combination chemotherapy. This medication works by depleting asparagine, an amino acid that cancer cells need to survive.
Key Facts
- Brand Name
- ONCASPAR
- Generic Name
- Pegaspargase
- NDC Code (Product)
72694-954- Manufacturer
- Servier Pharmaceuticals LLC
- Strength
- 750 [iU]/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR, INTRAVENOUS
- Marketing Status
- Application #
- BLA103411
- Drug Class
- Asparagine-specific Enzyme [EPC]
- Marketing Start
- 01/02/2020
Recall History
No Recall HistoryFrequently Asked Questions
What is ONCASPAR used for?
Oncaspar is a prescription injection used to treat certain types of leukemia and lymphoma as part of combination chemotherapy. This medication works by depleting asparagine, an amino acid that cancer cells need to survive.
Is ONCASPAR a controlled substance?
ONCASPAR is not classified as a controlled substance by the DEA.
What is the generic name for ONCASPAR?
The generic name for ONCASPAR is Pegaspargase. There are no other listed brand versions of Pegaspargase.
What is the NDC code for ONCASPAR 750 [iU]/mL?
The NDC (National Drug Code) for ONCASPAR 750 [iU]/mL is 72694-954, listed by Servier Pharmaceuticals LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)